Hosted on MSN
Novo Nordisk launches viral diabetes drug Ozempic in India: Starting weekly dose for INR 2,200
Novo Nordisk, the Denmark based pharma giant, has finally launched its hugely popular diabetes and weight-loss medicine, Ozempic, in the Indian market. Ozempic has recently garnered global recognition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results